Human Genome Epidemiology Literature Finder
|
Records 1 - 23 (of 23 Records) |
| Query Trace: Disease and GSK3B[original query] |
|---|
| Pharmacogenomics for the treatment of dementia. Annals of medicine 2002 34 (5): 357-79. Cacabelos Ram |
| GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. Annals of neurology 2005 Dec 58 (6): 829-39. Kwok John B J, Hallupp Marianne, Loy Clement T, Chan Daniel K Y, Woo Jean, Mellick George D, Buchanan Daniel D, Silburn Peter A, Halliday Glenda M, Schofield Peter |
| Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Annals of neurology 2007 Aug 62 (2): 145-53. Goris An, Williams-Gray Caroline H, Clark Graeme R, Foltynie Thomas, Lewis Simon J G, Brown Joanne, Ban Maria, Spillantini Maria G, Compston Alastair, Burn David J, Chinnery Patrick F, Barker Roger A, Sawcer Stephen |
| Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease. Annals of neurology 2008 Oct 64 (4): 446-54. Kwok John B J, Loy Clement T, Hamilton Gillian, Lau Edmond, Hallupp Marianne, Williams Julie, Owen Michael J, Broe G Anthony, Tang Nelson, Lam Linda, Powell John F, Lovestone Simon, Schofield Peter |
| Association of GSK3B with Alzheimer disease and frontotemporal dementia. Archives of neurology 2008 Oct 65 (10): 1368-74. Schaffer Barbara A J, Bertram Lars, Miller Bruce L, Mullin Kristina, Weintraub Sandra, Johnson Nancy, Bigio Eileen H, Mesulam Marsel, Wiedau-Pazos Martina, Jackson George R, Cummings Jeffrey L, Cantor Rita M, Levey Allan I, Tanzi Rudolph E, Geschwind Daniel |
| Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: a study from India. Neurobiology of aging 2012 Jul 33 (7): 1485.e9-15. Das Gautami, Misra Amar K, Das Shyamal K, Ray Kunal, Ray Jhar |
| SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study. European journal of neurology : the official journal of the European Federation of Neurological Societies 2010 Dec . Wider C, Vilariño-Güell C, Heckman MG, Jasinska-Myga B, Ortolaza-Soto AI, Diehl NN, Crook JE, Cobb SA, Bacon JA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA |
| Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese. Brain research 2011 May 1391 147-53. Zhang Na, Yu Jin-Tai, Yang Ying, Yang Jing, Zhang Wei, Tan L |
| Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype. Clinics (São Paulo, Brazil) 2013 68 (2): 277-80. Izzo Giselle, Forlenza Orestes V, Santos Bernardo dos, Bertolucci Paulo H F, Ojopi Elida B, Gattaz Wagner F, Kerr Daniel Shikan |
| MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China. BMC neuroscience 2014 15 (1): 54. Yu Lan, Huang Jinsha, Zhai Desheng, Liu Ling, Guo Kexin, Long Xi, Xiong Jing, Zhang Zhentao, Wang Youpei, Zhao Ying, Wu Ping, Wang Dingan, Lin Zhicheng, Wu Jing, Xiong Nian, Wang T |
| Comparable autoantibody serum levels against amyloid- and inflammation-associated proteins in Parkinson's disease patients and controls. PloS one 2014 9 (2): e88604. Maetzler Walter, Apel Anja, Langkamp Markus, Deuschle Christian, Dilger Sarah Selina, Stirnkorb Johannes Georg, Schulte Claudia, Schleicher Erwin, Gasser Thomas, Berg Danie |
| Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function. Journal of Alzheimer's disease : JAD 2015 44 (4): 1313-22. Kettunen Petronella, Larsson Susanna, Holmgren Sandra, Olsson Sandra, Minthon Lennart, Zetterberg Henrik, Blennow Kaj, Nilsson Staffan, Sjölander Anni |
| Beta-catenin in schizophrenia: Possibly deleterious novel mutation. Psychiatry research 2015 Aug 228 (3): 843-8. Levchenko Anastasia, Davtian Stepan, Freylichman Olga, Zagrivnaya Maria, Kostareva Anna, Malashichev Yeg |
| Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease. Journal of the neurological sciences 2016 Nov 370 162-166. Stefano Porcelli, Concetta Crisafulli, Luigi Donato, Marco Calabrò, Antonis Politis, Ioannis Liappas, Diego Albani, Anna Rita Atti, Raffaele Salfi, Ilaria Raimondi, Gianluigi Forloni, George N Papadimitriou, Diana De Ronchi, Alessandro Serret |
| Genome-wide network-based pathway analysis of CSF t-tau/Aß1-42 ratio in the ADNI cohort. BMC genomics 2017 May 18 (1): 421. Cong Wang, Meng Xianglian, Li Jin, Zhang Qiushi, Chen Feng, Liu Wenjie, Wang Ying, Cheng Sipu, Yao Xiaohui, Yan Jingwen, Kim Sungeun, Saykin Andrew J, Liang Hong, Shen Li, |
| Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Nov 28 (11): 2733-2740. Park S B, Kwok J B, Asher R, Lee C K, Beale P, Selle F, Friedlander |
| The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies. Translational psychiatry 2017 Jan 7 (1): e1007. Amare A T, Schubert K O, Klingler-Hoffmann M, Cohen-Woods S, Baune B |
| SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society 2019 Jun . Fernández-Santiago Rubén, Martín-Flores Núria, Antonelli Francesca, Cerquera Catalina, Moreno Verónica, Bandres-Ciga Sara, Manduchi Elisabetta, Tolosa Eduard, Singleton Andrew B, Moore Jason H, , Martí María-Josep, Ezquerra Mario, Malagelada Cristi |
| Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects. Frontiers in psychiatry 2018 9 702. Rampino Antonio, Marakhovskaia Aleksandra, Soares-Silva Tiago, Torretta Silvia, Veneziani Federica, Beaulieu Jean Mart |
| Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer's disease created by integrative analysis of multi-omics data. Alzheimer's research & therapy 2020 Nov 12 (1): 145. Shigemizu Daichi, Akiyama Shintaro, Higaki Sayuri, Sugimoto Taiki, Sakurai Takashi, Boroevich Keith A, Sharma Alok, Tsunoda Tatsuhiko, Ochiya Takahiro, Niida Shumpei, Ozaki Kouic |
| KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations. American journal of cancer research 2021 1 10 (12): 4464-4475. Zhang Xiaoshan, Zhang Ran, Chen Huiqin, Wang Li, Ren Chenghui, Pataer Apar, Wu Shuhong, Meng Qing H, Ha Min Jin, Morris Jeffrey, Xi Yuanxin, Wang Jing, Zhang Jianhua, Gibbons Don L, Heymach John V, Meric-Bernstam Funda, Minna John, Swisher Stephen G, Roth Jack A, Fang Binglia |
| Convergent lines of evidence supporting involvement of NFKB1 in schizophrenia. Psychiatry research 2022 06 312 114588. Long Jing, Tian Lin, Baranova Ancha, Cao Hongbao, Yao Yao, Rao Shuquan, Zhang Fuqu |
| Synergistic Effect between the APOE ?4 Allele with Genetic Variants of GSK3B and MAPT: Differential Profile between Refractory Epilepsy and Alzheimer Disease. International journal of molecular sciences 2024 9 25 (18): . Danira Toral-Rios, Pavel Pichardo-Rojas, Elizabeth Ruiz-Sánchez, Óscar Rosas-Carrasco, Rosa Carvajal-García, Dey Carol Gálvez-Coutiño, Nancy Lucero Martínez-Rodríguez, Ana Daniela Rubio-Chávez, Myr Alcántara-Flores, Arely López-Ramírez, Alma Rosa Martínez-Rosas, Ángel Alberto Ruiz-Chow, Mario Alonso-Vanegas, Victoria Campos-Pe |
- Page last reviewed:Feb 1, 2024
- Content source: